Published in Diabetes on July 01, 1997
Implementing clinical practice guidelines while taking account of changing evidence: ATHENA DSS, an easily modifiable decision-support system for managing hypertension in primary care. Proc AMIA Symp (2000) 2.12
Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis. Diabetologia (2011) 1.80
Cardiovascular disease prevention practices by U.S. Physicians for patients with diabetes. J Gen Intern Med (2000) 1.08
Therapeutic modalities in diabetic nephropathy: standard and emerging approaches. J Gen Intern Med (2011) 0.92
Progression of chronic renal failure in focal segmental glomerulosclerosis: consequence of podocyte damage or of tubulointerstitial fibrosis? Pediatr Nephrol (2003) 0.87
Therapeutic approaches to slowing the progression of diabetic nephropathy - is less best? Drugs Context (2013) 0.86
Peripheral vasoconstriction induced by β-adrenoceptor blockers: a systematic review and a network meta-analysis. Br J Clin Pharmacol (2016) 0.75
Management of Diabetic Nephropathy in the Elderly: Special Considerations. J Nephrol Ther (2012) 0.75
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med (2001) 22.32
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet (1999) 4.81
Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ (1991) 4.46
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet (1983) 3.01
Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy. Diabetes Care (2000) 2.97
Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) (1988) 2.84
Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) (1982) 2.75
Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ (1988) 2.65
Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int (1992) 2.51
Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J (Clin Res Ed) (1987) 2.35
Mechanisms of edema formation in myxedema--increased protein extravasation and relatively slow lymphatic drainage. N Engl J Med (1979) 2.21
Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ (1996) 2.00
Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int (2000) 1.85
Is diabetic nephropathy an inherited complication? Kidney Int (1992) 1.79
Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes. Diabetologia (2004) 1.75
Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J (Clin Res Ed) (1986) 1.68
Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia (1995) 1.57
Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism (1983) 1.56
Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. Kidney Int (2001) 1.55
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia (1981) 1.53
Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics. Diabetologia (1981) 1.53
Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes (1995) 1.51
Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy. Diabetologia (1990) 1.49
Monitoring kidney function in diabetic nephropathy. Diabetologia (1994) 1.47
Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1991) 1.47
Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int (2000) 1.46
Progression of diabetic nephropathy. Kidney Int (2001) 1.46
Diabetic nephropathy and arterial hypertension. Diabetologia (1983) 1.45
Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial. Diabetologia (2008) 1.44
Prevalence of microalbuminuria in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1986) 1.41
Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologia (1994) 1.40
Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients. Diabetes Care (1998) 1.40
Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus. J Clin Invest (1991) 1.36
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan). J Renin Angiotensin Aldosterone Syst (2000) 1.35
Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus. Diabet Med (2001) 1.34
Increased urinary albumin-excretion rate in benign essential hypertension. Lancet (1974) 1.28
Acute reduction of arterial blood pressure reduces urinary albumin excretion in type 1 (insulin-dependent) diabetic patients with incipient nephropathy. Diabetologia (1986) 1.26
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy. Kidney Int (2006) 1.24
Short stature and diabetic nephropathy. BMJ (1995) 1.24
Effect of intravenous glucose infusion on renal function in normal man and in insulin-dependent diabetics. Diabetologia (1981) 1.24
Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1993) 1.23
Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes. Kidney Int (2008) 1.23
Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes (1995) 1.20
The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics. Diabetologia (1976) 1.20
Glomerular structure and function in diabetic nephropathy. Early to advanced stages. Diabetes (1990) 1.18
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. Diabet Med (2010) 1.17
Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate. Diabetologia (2004) 1.14
Renal function in streptozotocin-diabetic rats. Diabetologia (1981) 1.13
Diabetic nephropathy and arterial hypertension. The effect of antihypertensive treatment. Diabetes (1983) 1.12
Changes in renal function during weight loss induced by high vs low-protein low-fat diets in overweight subjects. Int J Obes Relat Metab Disord (1999) 1.10
Benefits of long-term antihypertensive treatment on prognosis in diabetic nephropathy. Kidney Int (1996) 1.09
HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population. Tissue Antigens (1986) 1.08
Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy. Diabet Med (2000) 1.08
Anaemia in diabetes: Is there a rationale to TREAT? Diabetologia (2006) 1.08
QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes. Scand J Clin Lab Invest (2000) 1.08
Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy. Kidney Int Suppl (2000) 1.07
Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia (1984) 1.07
The effect of hypoxia and carbon monoxide exposure on plasma volume and capillary permeability to albumin. Scand J Clin Lab Invest (1972) 1.07
Increased serum concentration of von Willebrand factor in non-insulin dependent diabetic patients with and without diabetic nephropathy. BMJ (1995) 1.07
A strong correlation between glomerular filtration rate and filtration surface in diabetic nephropathy. Diabetologia (1988) 1.06
Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int (1982) 1.05
Efficacy and safety of insulin degludec given as part of basal-bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26-week randomized, open-label, treat-to-target non-inferiority trial. Diabetes Obes Metab (2014) 1.05
Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy. Diabetes Care (1996) 1.05
Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia (1989) 1.05
A combined abnormality in heart rate variation and QT corrected interval is a strong predictor of cardiovascular death in type 1 diabetes. Scand J Clin Lab Invest (2008) 1.04
Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type 2 diabetic patients. Diabet Med (2001) 1.03
Early changes in diabetic retinopathy: capillary loss and blood-retina barrier permeability in relation to metabolic control. Acta Ophthalmol (Copenh) (1994) 1.03